Professor Miriam Kolko is chief physician and glaucoma
specialist at the Copenhagen University Hospital,
Rigshospitalet and Professor of Translational Eye Research at the Department of Drug Design and Pharmacology at the University of Copenhagen. Miriam is president of the Danish Glaucoma Society, glaucoma chair of EVER, sits on the WGA Associate Advisory Board, and is co-chair for the EGS neuroprotection SIG. Miriam has been a scientific advisor for EYE-GO since 2023.

Professor Steffen Heegard is the Research Director at the Department of Ophthalmology at the Copenhagen University Hospital, Rigshospitalet, and professor at the University of Copenhagen. Steffen is the president of the Danish Ophthalmology Society and the European Ocular Oncology Group (OOG) and a board member of European Vision and Eye Research. Steffen has been a scientific advisor for EYE GO since 2016.

Marie is a commercial leader with over 25 years of experience in the pharmaceutical/medical device industry in the Nordic region, the last 12 years within the Eye Care/Ophthalmology segment. She is the Former General Manager at Bausch+Lomb Nordic AB. Marie has overseen strategic direction, operational excellence, financial performance, and a diverse portfolio of products and services with B+L. Marie has been a commercial advisor for EYE-GO since 2024.

Dave is a highly respected Commercial Executive with more than 30 years of experience in the Eye Care biopharmaceutical industry. He has extensive experience across all areas of commercialization in multiple therapeutic categories, technologies, and business models. He has led commercial strategy, launch planning, and in-market execution for pre-clinical assets, BD-acquired technology, and billion-dollar brands. Dave is the former Vice President with AbbVie/Allergan—U.S. Eye Care Sales and Marketing. He has been a commercial advisor for EYE-GO since 2024.

Arnaud is AbbVie’s former General Manager of the Eye Care division at Global Marketing and Commercial Operations level. He brings more than 20 years of  demonstrated success in commercial operations in the pharmaceutical industry, his experience covering the entire Product Life Cycle span in many different affiliates, Regional and Global roles within various therapeutic areas.  Arnaud has been a commercial advisor for EYE-GO since 2024.

Geert is an experienced CEO with a proven track record in medical diagnostics, biotech, and medical devices. He has international experience from both large and small organizations. Geert holds a strong commercial background supported by regulatory and quality knowledge, as well as substantial experience in leading publicly listed companies and interacting with the financial community. Geert has been a commercial advisor for EYE-GO since 2024.